Visunex Raises $20 Million in Series B Funding for Newborn Imaging Technology

May 12, 2017: By Jon Swedien

Vixunex logoVisunex Medical Systems, a manufacturer of advanced wireless, wide-field imaging systems for newborn infants, raised $20 million in a Series B funding, the Fremont, California, company announced May 5.

The firm introduced in 2016 the first wireless digital imaging platform for imaging the eye of neonatal and full term infants—the PanoCam LT.

“This new round of funding brings the total investment into Visunex Medical to $32 million and will allow the company to expand manufacturing operations to meet the market demand,” said Wei Su, PhD, Visunex’ founder and CEO.

Su said Visunex will also use the money to increase research and development.

Visunex said It will soon be adding a third imaging system to the PanoCam family, which currently consists of the LT and Pro wireless wide-field imaging systems. The new configuration is intended to expand the newborn and infant imaging market, the company said.

Need Deeper Analysis? Sign up for Market Scope's monthly newsletter to get in-depth coverage of the ophthalmic market, including quarterly procedure volumes based on survey data and meeting coverage from around the world.

Recent Ophthalmic News

US Health Secretary Alex Azar Takes Aim at Rebates in US Senate Hearing

Beyeonics Surgical Raises $11.5 Million in Initial Funding Round

MeiraGTx Raises $75 Million in Initial Public Offering

GenSight to Pursue Approval for LHON Gene Therapy Candidate, Despite Phase III Setback

Optovue Receives FDA Clearance for AngioAnalytics, First OCT Angiography Metrics

Nexy Robotic Retinal Imaging System Receives FDA Clearance

Ocutrx Receives US Patent for Oculenz AR Glasses for Macular Degeneration

Allergan’s Bimatoprost SR Demonstrates Noninferiority to Timolol in Phase III Glaucoma Study

KKR to acquire Envision Healthcare, Including Amsurg ASC Business

Ophthalmologist Carmen Puliafito, MD, Seeks to Regain Medical License

Avedro Gains J Code for Photrexa Formulations in Preliminary CMS Decision

EyeGate Seeks to Study Ocular Bandage Gel in Punctate Epitheliopathy

Nicox, Ironwood to Collaborate on Novel Ophthalmic Treatments

US FDA Approves MDGH’s Moxidectin for Treatment of River Blindness

Bausch + Lomb Enrolls First Patient in Trial for enVista MX60EF Trifocal IOL

Cincinnati Eye Institute Partners with Private Equity Firm to Pursue National Expansion

Ophthotech Enters Gene Therapy Deals with University of Florida, University of Pennsylvania

Teva’s Launches Generic Version of Restasis in Canada

Clearside’s Phase II Trial for DME Candidate Meets Primary Endpoint

Orasis Raises $13 Million in Series B Financing

Coming soon

2018 Optical Coherence Tomography Report: A Global Market Analysis for 2017 to 2023